SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0000950170-23-001224 from Marpai, Inc. (MRAI) (CIK 0001844392) (MRAI)

Marpai, Inc. (MRAI) (CIK 0001844392)
Date: Jan. 26, 2023 · CIK: 0001844392 · Accession: 0000950170-23-001224

AI Filing Summary & Sentiment

File numbers found in text: 333-269326

Date
January 26, 2023
Author
Not clearly detected
Form
CORRESP
Company
Marpai, Inc. (MRAI) (CIK 0001844392)

Letter

Marpai, Inc.

5701 East Hillsborough Ave., Suite 1417

Tampa, Florida 33610-5428

January 26, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

RE:

Marpai, Inc. (CIK: 0001844392)

Registration Statement No. 333-269326 on Form S-3 (the “Registration Statement”)

Ladies and Gentlemen:

DarioHealth Corp. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on January 30, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

The Registrant understands that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.

Very truly yours,
MARPAI, INC.

Show Raw Text
CORRESP
1
filename1.htm

  CORRESP

  Marpai, Inc.

  5701 East Hillsborough Ave., Suite 1417

  Tampa, Florida 33610-5428

  January 26, 2023

  VIA EDGAR

  Securities and Exchange Commission

  Division of Corporation Finance

  100 F Street, N.E.

  Washington, DC 20549

    RE:

    Marpai, Inc. (CIK: 0001844392)

    Registration Statement No. 333-269326 on Form S-3 (the “Registration Statement”)

  Ladies and Gentlemen:

  DarioHealth Corp. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on January 30, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

  The Registrant understands that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.

  Very truly yours,

  MARPAI, INC.

  By: /s/ Edmundo Gonzalez

  Edmundo Gonzalez, Chief Executive Officer